"Vasectomy Expert and NYC Urologist Jed Kaminetsky, MD offers the latest treatment and technologies to address urological concerns; enlarged prostate, overactive bladder, urinary tract infections, vasectomies - and more"

During the past decade, University Urology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 20 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Urology Associates" #1 sponsor was "Ferring Pharmaceuticals" with 7 trials, followed by "Clarus Therapeutics, Inc." with 3 trials sponsored, "Endo Pharmaceuticals" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "AEterna Zentaris" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Urology Associates" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Data & Inference, Inc." with 1 trials as a collaborator, "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center" with 1 trials as a collaborator, "Novella Clinical" with 1 trials as a collaborator and "PharmaNet" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "University Urology Associates" are "Nocturia" (4 trials), "Prostate Cancer" (4 trials), "Male Hypogonadism" (3 trials), "Peyronie's Disease" (3 trials) and "Adult Male Hypogonadism" (2 trials). Many other conditions were trialed in "University Urology Associates" in a lesser frequency.

Most popular intervention types in "University Urology Associates" are "Drug" (24 trials), "Biological" (5 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "AA4500" (3 trials), "Oral testosterone undecanoate" (3 trials), "Apaziquone" (2 trials) and "Degarelix" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Urology Associates" are 21 trials for "Male" genders and 10 trials for "All" genders.

Currently, there are NaN active trials in "University Urology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in University Urology Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University Urology Associates, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".